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heart failure is unknown and no effective therapy has 
been established 3）. 
Several recent cardiovascular studies have focused 
on complications of sleep-disordered breathing, includ-
ing obstructive sleep apnea syndrome 4〜6）, since sleep-
disordered breathing has been observed in 50％ of pa-
tients with stable heart failure 7） and the outcome of 
patients with heart failure accompanied by Cheyne-
Stokes respiration is poor 8）. Furthermore, obstructive 
sleep apnea syndrome has been related to hyperten-
sion, ischemic cardiac disease, arrhythmia and sudden 
death 9〜13）. However, there is no consensus regarding 
the occurrence of diastolic heart failure in patients 
with obstructive sleep apnea syndrome 14〜16） and the 
????????????
Diastolic heart failure with a preserved left ventricu-
lar ejection fraction is most commonly found in older 
and female patients with hypertension, and this condi-
tion accounts for approximately one-half of all heart 
failure cases and has an outcome similar to that of sys-
tolic heart failure 1, 2）. However, the cause of diastolic 
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Heart failure is frequently complicated by obstructive sleep apnea, which raises blood pressure and ar-
rhythmia and worsens prognosis. However, the incidence and influence of obstructive sleep apnea in pa-
tients with diastolic heart failure is unknown. We hypothesized that patients with diastolic heart failure 
complicated by obstructive sleep apnea may have a worse outcome compared to those without obstructive 
sleep apnea. The study included 49 patients with an ejection fraction ≥ 50％, of whom 34 had diastolic heart 
failure and 15 did not have diastolic heart failure. The patients were examined in a sleep study and by 
echocardiography. Brain natriuretic peptide （BNP） levels were determined at admission and 1, 6 and 12 
months thereafter. The prevalence of obstructive sleep apnea in patients with diastolic heart failure （18/34, 
53％） was significantly higher than that in those without diastolic heart failure （3/15, 20％）（p＝0.032）. 
BNP levels were high at admission in patients with diastolic heart failure, but then decreased gradually in 
those without obstructive sleep apnea. However, BNP in patients with diastolic heart failure and obstructive 
sleep apnea remained high and was significantly elevated compared to the level in patients without obstruc-
tive sleep apnea at 6 and 12 months after admission. Patients with diastolic heart failure and obstructive 
sleep apnea showed prolongation of elevated BNP, indicating that complication of diastolic heart failure by 
obstructive sleep apnea may aggravate cardiac function.
　???? ????： diastolic heart failure, obstructive sleep apnea, brain natriuretic peptide
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ygen saturation （SpO2） and pulse rate from 10 p.m. to 
6 a.m. Data was analyzed with the PULSOX analysis 
program. The frequency of reduction of SpO2 by ≥ 4％ 
and ≥ 3％ per hour （oxygen desaturation index） and 
the lowest SpO2 were used as parameters for sleep-
disordered breathing. Patients with 5 or more occur-
rences of oxygen desaturation of ≥ 4％ were examined 
by portable polysomnography including electroenceph-
alography, electro-oculogram, submental electromyo-
gram, airflow at nose and mouth, and respiratory effort 
（Sleep Watcher ®；Compumedics Ltd, Abbotsford, 
Australia） to assess obstructive sleep apnea. The pa-
rameters were analyzed by experienced technicians. 
The diagnosis of obstructive sleep apnea was based on 
the patients history and data of sleep study, and the 
apnea-hypopnea index was used as the measure of 
sleep-apnea severity 17）. In this study, obstructive sleep 
apnea was diagnosed based on a value of the apnea-
hypopnea index ≥ 5. Patients with an apnea-hypopnea 
index ≥ 5 were instructed regarding lifestyle changes, 
including weight loss. Patients with an apnea-hypo-
pnea index ≥ 20 were treated with appropriate thera-
py；continuous positive airway pressure after giving 
informed consent, that was maintained during the ob-
servation period. 
3. Echocardiography
Transthoracic echocardiography was performed 
with the patients in the left lateral decubitus position. 
2D- and M-mode echocardiography and color- and 
tissue-Doppler imaging were conducted using SONOS 
7500 （Philips Ultrasound, Bothell, Washington） and 
Vivid 7 （GE Vingmed Ultrasound AS, Horten, Nor-
way） systems. Imaging was performed by at least two 
cardiologists. Wall motion and valves were observed in 
2D-mode and valvular regurgitation was evaluated by 
color-flow imaging. The left atrial distance was mea-
sured in the cross-section of the parasternal long axis, 
and left ventricular fractional shortening was mea-
sured in M-mode in the same cross-section. The left 
ventricular end-diastolic volume and left ventricular 
end-systolic volume were determined in four- and 
two-chamber apical views and the left ventricular 
ejection fraction was estimated from these results. Left 
ventricular diastolic transmitral flow was recorded at 
the mitral valve leaflet in the pulse-Doppler apical 
outcome of diastolic dysfunction complicated by sleep-
disordered breathing has not been studied.
In this study, diastolic function was examined by 
echocardiography in patients with a left ventricular 
ejection fraction of ≥ 50％. The patients also under-
went a sleep study and the blood concentration of 
brain natriuretic peptide （BNP） was measured to as-
sess the effect of respiratory disorders in patients with 
diastolic heart failure.
???????
1. Patients
The subjects were patients with heart failure and a 
left ventricular ejection fraction of ≥ 50％ at screening 
who were admitted to our hospital between January, 
2004 and December, 2007. Heart failure was also deter-
mined based on a physical examination of clinical 
symptoms such as dyspnea, moist rale and abnormal 
heart sounds, and on chest X-rays. Patients were diag-
nosed with heart failure of New York Heart Associa-
tion class II, III or IV. The patients were treated for 
heart failure after admission, and underwent a sleep 
study and echocardiography when heart failure had 
improved. Informed consent was obtained from all pa-
tients in accordance with the ethical code of Dokkyo 
University School of Medicine. Patients with acute 
myocardial infarction, severe valvular heart disease, a 
serum creatinine level ＞1.2 mg/ml, or body mass in-
dex ＞30 were excluded from the study. 
Forty-nine patients （36 males and 13 females, mean 
age：65±10 years old） were enrolled in the study, 
comprising 34 with diastolic heart failure and 12 with-
out diastolic heart failure. Blood samples were collected 
at admission, 1 and 6 and 12 months thereafter. The 
blood was immediately transferred to a test tube con-
taining aprotinin and stored in ice or at 4ºC. After cen-
trifugation on the same day, blood BNP was deter-
mined using an enzyme-linked immunoassay kit. The 
normal level of BNP is＜18.4 pg/ml.
2. Sleep Study
At admission, all patients underwent screening by 
overnight pulse oximetry while breathing room air un-
der stable conditions. An oxygen saturation monitor 
（Pulsox-M24 ®；Konica Minolta Sensing Inc., JAPAN） 
was attached to the left fourth finger to determine ox-
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view. The peak early diastolic flow velocity （E）, E-
wave deceleration time, and peak atrial systolic flow 
velocity （A） were determined based on the blood flow 
patterns, and the ratio of the E-wave to the A-wave 
（E/A） was calculated. A wave and E/A could not ob-
tain in the patient of atrial fibrillation （n＝7）. The ear-
ly diastolic mitral annular velocity （E’） and atrial sys-
tolic mitral annular velocity （A’） were determined at 
the mitral annular septum in the pulse-Doppler four-
chamber apical view, and the E to E’ ratio （E/E’） was 
calculated. In this study, diastolic dysfunction was di-
agnosed based on a value of E/E’ ≥ 12 to make refer-
ence to 18, 19）. These parameters were determined by 
recording at least 3 cardiac cycles under stable condi-
tions and the mean of the measurements was used for 
analysis.
4. Statistical Analysis
Data are presented as means±standard deviation. 
Statistical analysis was conducted using analysis of 
variance （ANOVA） followed by an unpaired Student 
t-test and chi-squared test using SPSS statistical soft-
ware, version 14.0. A p-value＜0.05 was considered to 
be significant.
???????
There were no significant differences in age, heart 
rate and blood pressure among patients with and with-
out diastolic heart failure at admission, but treatment 
with b-blockers and diuretics was significantly more 
frequent in patients with diastolic heart failure （Table 
1）. The prevalence of obstructive sleep apnea in pa-
tients with diastolic heart failure （18/34, 53％） was 
significantly higher than that in patients without dia-
stolic heart failure （3/15, 20％）（p＝0.032）, and in the 
sleep study, these group had a higher apnea-hypopnea 
index, lowest saturation and higher 3％ and 4％ oxy-
gen desaturation indices （Table 2）. Among the pa-
tients with diastolic heart failure, there were no signifi-
cant differences in clinical characteristics, heart rate, 
and blood pressure between those with and without 
obstructive sleep apnea （Table 3）. 
In echocardiography, the E/E’ ratio was higher in 
patients with diastolic heart failure compared to those 
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???????　Characteristics of patients with and without diastolic heart failure
with HF
（n＝34）
without HF
（n＝15）
p-value
Age （years）
Male, n （％）
Heart rate （beats/min）
Systolic blood pressure （mmHg）
Diastolic blood pressure （mmHg）
Body mass index （kg/m2）
History of illness, n （％）
　Hypertension
　Ischemic heart disease
　Atrial fibrillation
　Diabetes mellitus
　Hyperlipidemia
　Hyperuricemia
Obstructive sleep apnea
Medication, n （％）
　Calcium antagonists
　Beta-blockers
　ACE inhibitors
　Angiotensin II receptor blockers
　Diuretics
　Aspirin
 66±9
26 （77）
 73±14
138±27
 80±15
 25±3.0
21 （62）
16 （47）
 7 （21）
10 （29）
 9 （26）
1 （3）
18 （53）
13 （38）
11 （32）
 8 （24）
24 （71）
17 （50）
24 （71）
 63±11
10 （67）
 76±12
136±16
 78±15
 26±2.2
10 （67）
 3 （20）
 4 （27）
 3 （20）
 4 （27）
0
 3 （20）
7 （47）
1 （7）
0
 9 （60）
 3 （20）
10 （67）
0.21
0.48
0.42
0.67
0.6
0.42
0.34
0.19
0.56
0.89
0.54
0.58
0.032
0.59
0.01
0.04
0.48
0.05
0.79
HF；heart failure, ACE, Angiotensin-converting enzyme
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without diastolic heart failure, but the difference was 
not significant （Table 4）. There were no differences in 
ejection fraction, fractional shortening, E- and A-
waves, E/A ratio, the E-wave deceleration time, and 
E/E’ ratio in patients with diastolic heart failure with 
and without obstructive sleep apnea （Table 5）. 
At admission, the concentration of BNP was elevated 
in patients with diastolic heart failure with and without 
obstructive sleep apnea （609.8±395.6 and 494.8±
628.5 pg/ml, respectively）（Figure 1）. In patients with 
diastolic heart failure without obstructive sleep apnea, 
the BNP level decreased to 88.8±65.3 pg/ml at 1 
month after admission, to 65.4±31.8 pg/ml after 6 
months, and to 62.6±48.6 pg/ml after 12 months. In 
contrast, in patients with diastolic heart failure with 
obstructive sleep apnea the BNP level remained high 
at 1279.5±206.2 pg/ml at 1 month after admission, at 
224.9±175.7 pg/ml after 6 months, and at 225.1±
188.6 pg/ml after 12 months. The BNP levels in heart 
failure patients with obstructive sleep apnea at 1, 6 
4 DJMS
???????　 Characteristics of heart failure patients with and without obstructive 
sleep apnea
OSA （＋）
（n＝18）
OSA （−）
（n＝16）
p-value
Age （years）
Male, n （％）
Heart rate （beats/min）
Systolic blood pressure （mmHg）
Diastolic blood pressure （mmHg）
Body mass index （kg/m2）
History of illness, n （％）
　Hypertension
　Ischemic heart disease
　Atrial fibrillation
　Diabetes mellitus
　Hyperlipidemia
　Hyperuricemia
Medication, n （％）
　Calcium antagonists
　Beta-blockers
　ACE inhibitors
　Angiotensin II receptor blockers
　Diuretics
　Aspirin
67±7
14 （78）
77±17
140±30
82±14
25±2.5
 6 （33）
 6 （33）
11 （61）
 3 （17）
 4 （22）
1 （6）
 6 （33）
10 （56）
 3 （24）
12 （71）
10 （50）
12 （71）
66±11
12 （75）
 68±9
136±21
 77±16
 24±3.5
1 （6）
10 （63）
10 （63）
 7 （44）
 5 （31）
1 （6）
 7 （44）
 7 （44）
 5 （31）
12 （60）
 7 （10）
12 （60）
0.79
0.86
0.07
0.75
0.40
0.14
0.05
0.09
0.94
0.09
0.57
0.93
0.55
0.51
0.33
0.61
0.51
0.61
ACE, Angiotensin-converting enzyme
???????　Data of sleep study
OSA with HF （n＝18） OSA without HF （n＝3） p-value
Obstructive apnea index （events/hour）
Central apnea index （events/hour）
Mixed apnea index （events/hour）
Apnea-hypopnea index （events/hour）
Lowest O2 saturation （％）
3％ oxygen desaturation index＊
4％ oxygen desaturation index＊＊
16.9±16.0
4.2±6.4
2.7±2.1
36.2±17.1
77.8±10.9
29.5±15.3
25.4±15.4
14.7±5.8
 6.6±7.8
 9.9±7.7
44.4±5.4
60.4±12.1
36.0±9.5
35.3±21.1
0.82
0.57
0.003
0.45
0.021
0.48
0.29
＊；The frequency of reduction of oxygen saturation by 3％ per hour. ＊＊；The frequency of reduction of 
oxygen saturation by 4％ per hour.
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???????　Echocardiographic findings in patients with and without heart failure
with HF
（n＝34）
without HF
（n＝15）
p-value
Heart rate （beats/min）
Left atrial dimension （mm）
End-diastolic volume （ml）
End-systolic volume （ml）
Ejection fraction （％）
Fractional shortening （％）
E wave （m/s）
A wave （m/s）
E/A ratio
E wave deceleration time （ms）
E/E’ ratio
Valvular regurgitation, n （％）
　Mitral
　Aortic
　Tricuspid
　Pulmonary
  66±12
  40±7
 106±36
  45±21
  61±8
  33±10
0.73±0.26
0.79±0.18 1）
0.90±0.41 1） 
 201±50
15.7±4.9
8 （24）
6 （18）
8 （24）
6 （18）
  58±15
  38±5
  95±24
  36±21
  66±10
  37±9
0.64±0.17
0.73±0.17 2）
0.88±0.24 2）
 206±38
12.5±0.5
3 （20）
1 （7）
6 （40）
2 （13）
0.48
0.38
0.40
0.19
0.06
0.34
0.25
0.26
0.90
0.75
0.05
0.89
0.51
0.14
1
1）；excluded 6 cases of atrial fibrillation. 2）；excluded 1 case of atrial fibrillation. 
E wave；mitral valve early diastolic velocity, A wave；mitral valve late 
diastolic velocity, E/E’ ratio；ratio of mitral valve velocity to mitral annular 
early diastolic velocity.
???????　 Echocardiographic findings in heart failure patients with and 
without obstructive sleep apnea
OSA （＋）
（n＝18）
OSA （−）
（n＝16）
p-value
Heart rate （beats/min）
Left atrial dimension （mm）
End-diastolic volume （ml）
End-systolic volume （ml）
Ejection fractoin （％）
Fractional shortening （％）
E wave （m/s）
A wave （m/s）
E/A ratio
E wave deceleration time （ms）
E/E’ ratio
Valvular regurgitation, n （％）
　Mitral
　Aortic
　Tricuspid
　Pulmonary
  67±15
  41±7
 107±37
  45±19
  62±8
  34±11
0.77±0.25
0.79±0.18 1）
0.92±0.43 1）
 202±52
15.4±4.5
3 （17）
5 （28）
5 （28）
3 （17）
  64±8
  39±7
 103±36
  46±23
  59±8
  32±9
0.68±0.27
0.80±0.18 2）
0.88±0.41 2）
 201±48
16.1±5.5
5 （31）
1 （6）
3 （19）
3 （19）
0.46
0.39
0.75
0.95
0.3
0.5
0.32
0.84
0.78
0.95
0.72
0.32
0.11
0.55
0.94
1）；excluded 5 cases of atrial fibrillation. 2）；excluded 1 case of atrial 
fibrillation. E wave；mitral valve early diastolic velocity, A wave；mitral valve 
late diastolic velocity, E/E’ ratio；ratio of mitral valve velocity to mitral 
annular early diastolic velocity.
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and 12 months after admission were significantly high-
er than the respective levels in patients without ob-
structive sleep apnea. In patients without heart failure 
and obstructive sleep apnea, the BNP level was not 
significantly elevated and changed during the observa-
tion period；25.3±13.4 pg/ml at admission, 13.8±
13.1 pg/ml at 1 month after admission, 45.0±60.7 pg/
ml after 6 months, and 39.0 ± 31.4 pg/ml after 12 
months. 
??????????
The results of the study showed that the incidence 
of obstructive sleep apnea was significantly higher in 
patients with diastolic heart failure compared with 
those without diastolic heart failure. Left ventricular 
diastolic heart failure is observed when left ventricular 
systolic function is normal, and heart failure guidelines 
now define diastolic heart failure as “heart failure with 
a preserved ejection fraction”20）. Senni et al. reported 
that 43％ of heart failure patients had diastolic heart 
failure and that their outcome did not differ from that 
of patients with systolic heart failure 3）. However, the 
mortality of diastolic heart failure has gradually in-
creased 1）. The conventional assessment method for 
evaluation of clinical diastolic function is recording of 
left ventricular diastolic transmitral flow patterns （E- 
and A-waves） by pulse-Doppler echocardiography 21）, 
whereas the newest approach uses a combination of 
this method and recording of the early diastolic mitral 
annular velocity （E’） and atrial systolic mitral annular 
velocity （A’） by tissue-Doppler imaging 18, 19）.
Sleep apnea syndrome is a common complication in 
patients with heart failure, and leads to a poor progno-
sis through elevation of blood pressure and induction 
of myocardial ischemia and arrhythmia due to in-
creased sympathetic nervous system activity 22）. Ob-
structive sleep apnea severely influence prognosis and 
mortality in patients with systolic heart failure 22）, and 
Fung et al. reported that severe obstructive sleep ap-
nea with an apnea-hypoxia index of 40 or higher is re-
lated to left ventricular diastolic relaxation 15）. 
BNP is secreted mainly from the ventricular wall fol-
lowing overload of pressure and volume in the ventri-
cle and extension of the ventricular wall 23）. The BNP 
level is useful for diagnosis of acute heart failure 24） and 
diastolic dysfunction 25）. Bursi et al. classified diastolic 
function into four levels using a combination of pulse- 
and tissue-Doppler imaging and showed that higher 
levels of BNP are associated with more severe diastolic 
dysfunction 26）. 
In the current study, 39 patients with a mean E/E’ 
ratio of 15.7 and a mean BNP level of 550 pg/ml at ad-
mission were diagnosed with diastolic heart failure. 
Among these patients, the BNP level was significantly 
higher in those with obstructive sleep apnea at 1, 6 
and 12 months after admission for treatment of heart 
failure. In obstructive sleep apnea, intrathoracic pres-
sure during inspiration is rapidly reduced at night and 
it is assumed that the increase of venous return and 
left ventricular afterload may result in overload of 
pressure and volume in the left ventricle. BNP secre-
tion from the left ventricular wall may be induced by 
diastolic dysfunction and further increased every night 
by obstructive sleep-induced increases in venous re-
turn and left ventricular afterload mismatching of in-
creased myocardial oxygen demand and decreased ox-
ygen supply caused by apnea. Futher studies are 
required to elucidate the details of this mechanism. 
The study has several limitations. First, patients 
were treated for obstructive sleep apnea with the 
therapy of the continuous positive airway pressure 
during the observation period, but the effect of treat-
6 DJMS
????????　 Brain natriuretic peptide concentration of heart 
failure patients with and without obstructive 
sleep apnea.
The brain natriuretic peptide （BNP） concentration in 
heart failure patients with obstructive sleep apnea （■） 
was significantly higher at 1, 6 and 12 months compared 
to the respective levels in heart failure patients without 
obstructive sleep apnea （□）. M；month.
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ment for obstructive sleep apnea was not assessed in 
this study. Second, a prospective study would be use-
ful for understanding the influence of obstructive sleep 
apnea in patients with diastolic heart failure, because 
the current study was a retrospective investigation. 
Further studies are required to elucidate the details of 
the relationship between diastolic heart failure and ob-
structive sleep apnea, but our results indicate that pa-
tients with diastolic heat failure complicated with ob-
structive sleep apnea may have aggravation of cardiac 
dysfunction.
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